Skip to main content
Resource Center
bioMérieux Worldwide
Discover all our locations
Asia
China (Website)
India (Website)
Indonesia (website)
Japan (Website)
Korea
Malaysia (website)
Philippines (website)
Singapore (Website)
Thailand (website)
Vietnam (website)
Europe, Middle East, Africa
Algeria
Austria (Website)
Belgium
Czech Republic (Website)
Denmark (Website)
Finland (Website)
France (Website)
Germany (Website)
Greece
Hungary (Website)
Italy (Website)
Ivory Coast
Netherlands
Norway (Website)
Poland (Website)
Portugal (Website)
Russia (Website)
Serbia
South Africa (Website)
Spain (Website)
Sweden (Website)
Switzerland (Website)
Türkiye (Website)
United Arab Emirates
United Kingdom (Website)
North America
Canada (Website)
United States (Website)
Oceania
Australia (Website)
New Zealand (Website)
South America
Argentina (Website)
Brazil (Website)
Chile (Website)
Colombia (Website)
Mexico (Website)
Our Specific Websites
Antimicrobial Resistance Website
BioFire Diagnostics
bioMérieux Clinical Diagnostics
bioMérieux Industry
bioMérieux Recruitment
bioMérieux Culture Media
Search form
Search
United Kingdom & Ireland
Need information ?
CONTACT US
Main menu
Clinical Diagnostics
Products/Services
By speciality
By pathology
AZ list
Solutions
Antimicrobial Resistance Management
C.difficile Infection Management
HIV Diagnostics & Management
Emergency Department Patient Management
Lab Efficiency
Sepsis
Your Challenges
Healthcare Executive Challenges
Lab Challenges
Physician Challenges
Industrial Microbiology
News & Events
Resources
Customer service
Healthcare Information
Clinician booklets
Antimicrobial Resistance Newsletters
Industry Newsletters
About Micro-organisms
About us
Our Company
Our Commitments
bioMérieux Worldwide
Resource Center
My selection (
0
)
Pioneering Diagnostics
bioMérieux United Kingdom & Ireland | Pioneering Diagnostics
LATEST NEWS
31.01.2023
MAESTRIA™, a new generation microbiology middleware developed by bioMérieux to optimize laboratory workflow and improve patient care
13.05.2022
bioMérieux announces the CE marking of VIDAS® tests for Chikungunya virus diagnosis
04.05.2022
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel
18.03.2022
bioMérieux receives FDA 510(k) clearance for its VITEK® MS PRIME new MALDI-TOF mass spectrometry identification system
02.12.2021
bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron variant
ALL NEWS
NEXT EVENT
11.05.2021
COVID-19: The Infection Challenging the World
ALL EVENTS
Clinical solutions
Products & Services
Learn more about bioMérieux’s Clinical Products & Services
Solutions
Discover our solutions to current key problem areas
Your Challenges
Did you know we address the issues of labs, physicians and healthcare executives?
Industrial solutions
Food
Solutions for Food safety & Food quality
Biopharma
Microbial Control Solutions for bioPharmaceutical Industries
Veterinary
Solutions for Veterinary Diagnostics
Cosmetics
Microbial Control Solutions for Cosmetics & Personal Care Industries